Clinical Trial Update: Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update for CHF 6532 in uncontrolled severe eosinophilic asthma; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• CHF 6532

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma; Eosinophilic | Phase 3 | Status: TERMINATED